Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cataract Oral vs IV Sedation Pilot RCT
NCT07154147Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Aug 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alprazolam in cataract, sponsored by University of California, San Francisco. Started Aug 2025; status: completed.
02
Drugs
alprazolam
03
Conditions
cataract
Beyond the preview
Go deeper on NCT07154147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07154147.